Flexible Flat-Rate Plans
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
DrugPatentWatch Database Preview
Novartis Company Profile
« Back to Dashboard
Summary for Applicant: Novartis
| Patents: | 176 |
| Tradenames: | 158 |
| Ingredients: | 138 |
| NDAs: | 193 |
| Drug Master File Entries: (click here to view) | 25 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | VALTURNA | aliskiren hemifumarate; valsartan | TABLET;ORAL | 022217-002 | Sep 16, 2009 | DISCN | No | 5,559,111 | Jul 21, 2018 | Y | Y | ||||||||||||||||||
Novartis Pharms Corp | PROMACTA | eltrombopag olamine | TABLET;ORAL | 022291-004 | Oct 20, 2011 | RX | No | Feb 26, 2022 | |||||||||||||||||||||
Novartis | ZOMETA | zoledronic acid | INJECTABLE;IV (INFUSION) | 021223-003 | Jun 17, 2011 | RX | Yes | 7,932,241 | Feb 5, 2028 | Y | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Similar Applicant Names
Here is a list of applicants with similar names.
« Back to Dashboard
For more information try a trial or see the database preview and plans and pricing
How are People Using DrugPatentWatch?
To study drug patents and develop plans to synthesize molecules without infringing their patents
— Asst R&D manager, UK
To get information on expired patents
— Patent Attorney, USA
To check for Australian drug patents
— Big Pharma, Ireland
For paragraph IV challenge research
— Pharmaceutical company, USA
To find out patent expiration data for the Czech Republic
— Doctor, Czech Republic
To follow up on status of patents in Colombia and other Latin American countries
— Business development, Colombia
To be informed abut patent protection and patent challenges
— Business development / Licensing / Marketing & sales, Italy
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639
